TFSL vs. ABBV
TFSL (TFS Financial Corporation) and ABBV (AbbVie Inc.) are both stocks. TFSL operates in Banks - Regional (Financial Services), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, TFSL returned 5.20%/yr vs 17.56%/yr for ABBV. At a 0.20 correlation, their price movements are largely independent.
Performance
TFSL vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TFSL achieves a 21.01% return, which is significantly higher than ABBV's -3.41% return. Over the past 10 years, TFSL has underperformed ABBV with an annualized return of 5.20%, while ABBV has yielded a comparatively higher 17.56% annualized return.
TFSL
- 1D
- -1.18%
- 1M
- 6.30%
- YTD
- 21.01%
- 6M
- 14.83%
- 1Y
- 31.06%
- 3Y*
- 18.27%
- 5Y*
- 0.96%
- 10Y*
- 5.20%
ABBV
- 1D
- 0.80%
- 1M
- 4.31%
- YTD
- -3.41%
- 6M
- -4.15%
- 1Y
- 19.73%
- 3Y*
- 20.88%
- 5Y*
- 18.44%
- 10Y*
- 17.56%
TFSL vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TFSL TFS Financial Corporation | 21.01% | 15.95% | -6.73% | 11.18% | -12.98% | 7.13% | -4.53% | 29.24% | 13.93% | -18.48% |
ABBV AbbVie Inc. | -3.41% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between TFSL and ABBV is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013 | 0.20 |
The correlation between TFSL and ABBV shifts across timeframes, from 0.05 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.
Fundamentals
TFSL:
$4.44B
ABBV:
$385.19B
TFSL:
$0.33
ABBV:
$2.05
TFSL:
47.85
ABBV:
105.79
TFSL:
5.52
ABBV:
6.13
TFSL:
2.31
ABBV:
14.01
TFSL:
$806.96M
ABBV:
$62.82B
TFSL:
$249.75M
ABBV:
$46.15B
TFSL:
$100.48M
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TFSL vs. ABBV — Risk / Return Rank
TFSL
ABBV
TFSL vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TFS Financial Corporation (TFSL) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TFSL | ABBV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.40 | 0.83 | +0.57 |
Sortino ratioReturn per unit of downside risk | 1.99 | 1.30 | +0.69 |
Omega ratioGain probability vs. loss probability | 1.25 | 1.16 | +0.09 |
Calmar ratioReturn relative to maximum drawdown | 2.88 | 1.14 | +1.74 |
Martin ratioReturn relative to average drawdown | 7.56 | 2.57 | +4.99 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TFSL | ABBV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.40 | 0.83 | +0.57 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.04 | 0.81 | -0.77 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.21 | 0.68 | -0.47 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.73 | -0.50 |
Drawdowns
TFSL vs. ABBV - Drawdown Comparison
The maximum TFSL drawdown since its inception was -45.52%, roughly equal to the maximum ABBV drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for TFSL and ABBV.
Loading charts...
Drawdown Indicators
| TFSL | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.52% | -45.09% | -0.43% |
Max Drawdown (1Y)Largest decline over 1 year | -10.83% | -17.32% | +6.49% |
Max Drawdown (3Y)Largest decline over 3 years | -24.68% | -20.74% | -3.94% |
Max Drawdown (5Y)Largest decline over 5 years | -42.95% | -21.92% | -21.03% |
Max Drawdown (10Y)Largest decline over 10 years | -42.95% | -45.09% | +2.14% |
Current DrawdownCurrent decline from peak | -1.18% | -9.04% | +7.86% |
Average DrawdownAverage peak-to-trough decline | -17.21% | -10.73% | -6.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.12% | 7.69% | -3.57% |
Volatility
TFSL vs. ABBV - Volatility Comparison
The current volatility for TFS Financial Corporation (TFSL) is 5.05%, while AbbVie Inc. (ABBV) has a volatility of 5.42%. This indicates that TFSL experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TFSL | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.05% | 5.42% | -0.37% |
Volatility (6M)Calculated over the trailing 6-month period | 16.41% | 17.61% | -1.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.26% | 23.96% | -1.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.65% | 22.84% | +0.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.51% | 25.74% | -1.23% |
Dividends
TFSL vs. ABBV - Dividend Comparison
TFSL's dividend yield for the trailing twelve months is around 7.12%, more than ABBV's 3.10% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.10% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
TFSL TFS Financial Corporation | 7.12% | 8.45% | 9.00% | 7.69% | 7.84% | 6.30% | 6.35% | 5.28% | 5.21% | 3.95% | 2.36% | 1.81% |
Financials
TFSL vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between TFS Financial Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TFSL vs. ABBV - Profitability Comparison
TFSL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TFS Financial Corporation reported a gross profit of 0.00 and revenue of 195.47M. Therefore, the gross margin over that period was 0.0%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
TFSL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TFS Financial Corporation reported an operating income of 0.00 and revenue of 195.47M, resulting in an operating margin of 0.0%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
TFSL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TFS Financial Corporation reported a net income of 23.25M and revenue of 195.47M, resulting in a net margin of 11.9%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
TFSL and ABBV have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABBV has higher volatility (5.42%) compared to TFSL (5.05%). In terms of maximum drawdown, TFSL dropped -45.52% vs ABBV's -45.09%.
TFSL currently has the higher Sharpe Ratio (1.40 vs 0.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TFSL and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer